Show simple item record

dc.contributor.authorSilva, Fabio H.
dc.contributor.authorGodoy, Beatriz P. B.
dc.contributor.authorAlexandre, Eduardo C.
dc.contributor.authorCalmasini, Fabiano B.
dc.contributor.authorSantos, Jean L. dos [UNESP]
dc.contributor.authorCosta, Fernando F.
dc.date.accessioned2019-10-04T12:40:57Z
dc.date.available2019-10-04T12:40:57Z
dc.date.issued2019-08-15
dc.identifier.citationJournal Of Translational Medicine. London: Bmc, v. 17, n. 1, 1 p., 2019.
dc.identifier.urihttp://hdl.handle.net/11449/186076
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.format.extent1
dc.language.isoeng
dc.publisherBmc
dc.relation.ispartofJournal Of Translational Medicine
dc.sourceWeb of Science
dc.titleEffect of treatment with a new nitric oxide donor, a hybrid derived from resveratrol and furoxan (E)-4-(4-(4-methoxystyryl)phenoxy)-3-methyl-1,2,5-oxadiazole-2-oxide, on priapism in sickle cell mouse and nitric oxide-deficient mouseen
dc.typeResumo
dcterms.rightsHolderBmc
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.description.affiliationUniv Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
dc.description.affiliationUniv Estadual Campinas, Dept Pharmacol, Campinas, SP, Brazil
dc.description.affiliationUNESP, Lab Pesquisa & Desenvolvimento Farmacos, Araraquara, Brazil
dc.description.affiliationUnespUNESP, Lab Pesquisa & Desenvolvimento Farmacos, Araraquara, Brazil
dc.identifier.wosWOS:000482649700079
dc.rights.accessRightsAcesso restrito
dc.description.sponsorshipIdFAPESP: 2017/08122-9
dc.description.sponsorshipIdFAPESP: 2018/06243-6
Localize o texto completo

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record